Extracellular vesicles from N2-like neutrophils enhance triple-negative breast cancer aggressiveness through an L-selectin-dependent protumoral signaling axis.

Amorim C, Amorim NS, Frony AC, Santos RCMD, Miranda BT, Pires GS, Pinheiro PSM, De-Freitas-Junior JCM, Renovato-Martins M, Barja-Fidalgo C, Moraes JA

Open source

DOI
10.1016/j.intimp.2026.117361
Published
2026 Sep 11
Container
International immunopharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.intimp.2026.117361,
  title = {Extracellular vesicles from N2-like neutrophils enhance triple-negative breast cancer aggressiveness through an L-selectin-dependent protumoral signaling axis.},
  author = {Amorim C and Amorim NS and Frony AC and Santos RCMD and Miranda BT and Pires GS and Pinheiro PSM and De-Freitas-Junior JCM and Renovato-Martins M and Barja-Fidalgo C and Moraes JA},
  year = {2026},
  journal = {International immunopharmacology},
  doi = {10.1016/j.intimp.2026.117361},
  url = {https://doi.org/10.1016/j.intimp.2026.117361}
}

RIS

TY  - JOUR
TI  - Extracellular vesicles from N2-like neutrophils enhance triple-negative breast cancer aggressiveness through an L-selectin-dependent protumoral signaling axis.
AU  - Amorim C
AU  - Amorim NS
AU  - Frony AC
AU  - Santos RCMD
AU  - Miranda BT
AU  - Pires GS
AU  - Pinheiro PSM
AU  - De-Freitas-Junior JCM
AU  - Renovato-Martins M
AU  - Barja-Fidalgo C
AU  - Moraes JA
PY  - 2026
JO  - International immunopharmacology
DO  - 10.1016/j.intimp.2026.117361
UR  - https://doi.org/10.1016/j.intimp.2026.117361
ER  - 

APA

C, A., NS, A., AC, F., RCMD, S., BT, M., GS, P., PSM, P., JCM, D., M, R., C, B., & JA, M. (2026). Extracellular vesicles from N2-like neutrophils enhance triple-negative breast cancer aggressiveness through an L-selectin-dependent protumoral signaling axis.. International immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117361

Source records